Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?
Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Today's Oncology News: Gene Predisposing Neuroblastoma Identified
D Scott Cunningham MD, PhD, MDLinx Oncology
FDA Update: Researchers Enhance Cancer-Fighting Potential of Lycopene
Tracy Hampton, PhD, MDLinx Oncology
Cancer Science: Lighting Up Metastases: New Virus Highlights Prostate Cancer Spread
Sara Hartley, MDLinx Oncology
  See all
unresectable hepatic metastasis; radioembolization Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Radioembolization for Unresectable Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres: Early Results in 148 Patients
American Journal of Clinical Oncology, 06/09/08
Print     Email This Article     Save in My Library   Free Abstract
Kennedy AS et al. - Radioembolization with 90Y-microspheres to the whole liver, or lobe with single or multiple fractions are safe and produce high response rates, even with extensive tumor replacement of normal liver and/or heavy pretreatment. The acute and delayed toxicity was very low without a treatment related grade 4 acute event or radiation induced liver disease in this modest-sized cohort. The significant objective response suggests that further investigation of this approach is warranted.
 

--- DIAGNOSTICS/RADIOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

--- ENDOCRINE ONCOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

Sponsor
--- HEPATOBILIARY/PANCREAS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Quality-of-Life Assessment for Routine Oncology Clinical Practice
The Journal of Supportive Oncology, 06/16/08

Surgery for gallbladder cancer: A population-based analysis
Journal of the American College of Surgeons, 08/18/08

Sorafenib in advanced hepatocellular carcinoma
New England Journal of Medicine, 07/25/08


Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
 Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
 Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
     Medical Students
Nurse Practitioner
Pharma/Drug Marketer
     Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.